Naltrexone, opiate addiction, and endorphins.
D000818:Animals; D001066:Appetite / Q000187:drug effects; D001521:Behavior Therapy; D001835:Body Weight / Q000187:drug effects; D004341:Drug Evaluation; D004702:Endocrine Glands / Q000378:metabolism; D004723:Endorphins / Q000378:metabolism*; D006801:Humans; D008125:Locus Coeruleus / Q000378:metabolism; D009270:Naloxone / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D009271:Naltrexone / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D009420:Nervous System / Q000378:metabolism; D009293:Opioid-Related Disorders / Q000378:metabolism / Q000534:rehabilitation*; D010349:Patient Compliance; D011957:Receptors, Opioid / Q000378:metabolism; D013375:Substance Withdrawal Syndrome / Q000378:metabolism
D004723:Endorphins; D011957:Receptors, Opioid; D009270:Naloxone; D009271:Naltrexone